Print Page | Contact Us | Sign In | Join ASFA
JCA Online Access

 Journal of Clinical Apheresis Online Access

  

 


The Journal of Clinical Apheresis, the official publication of ASFA, provides the world's premier source of current information in the field of apheresis. The Journal presents work in all aspects of basic and clinical research, practical applications, emerging technologies and regulation in apheresis and related fields including hematology, nephrology, neurology, rheumatology, transplantation, cellular therapies, blood banking, transfusion medicine and others.

Publication Schedule:

The 2018/2019 Journal of Clinical Apheresis publication schedule is as follows:

     2018
     Volume 33, Issue 1: February 2018
     Volume 33, Issue 2: April 2018
     Volume 33, Issue 3: June 2018
     Volume 33, Issue 4: August 2018
     Volume 33, Issue 5: October 2018
     Volume 33, Issue 6: December 2018

     2019
     Volume 34, Issue 1: February 2019
     Volume 34, Issue 2: April 2019
     Volume 34, Issue 3: June 2019
     Volume 34, Issue 4: August 2019
     Volume 34, Issue 5: October 2019
     Volume 34, Issue 6: December 2019

 

 

 

Online Access

ASFA Members can log in to their ASFA account and access the online version of the Journal of Clinical Apheresis by clicking below:
 

 

JCA Online Access

 

 

 

 

DISCLAIMER It is the intent of the American Society for Apheresis (ASFA), the authors and the editors, to provide current and accurate information to the reader. Furthermore, ASFA, the authors and the editors disclaim any responsibility for any adverse event as a consequence, directly or indirectly, from the application of any suggested treatment, protocol, and/or procedure. Nor will ASFA, the authors or the editors accept responsibility for any undetected errors or misunderstanding of any information contained in this document. The apheresis principles, policies, and procedures described in this document must be prescribed by a qualified physician and administered under the supervision of a qualified physician (as outlined in the ASFA publication Organizational Guidelines For Therapeutic Apheresis Facilities and the ASFA Clinical Applications and Standards Committee) and in accordance with applicable Federal, State, and Local regulatory agency requirements.